Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients

ML Frémond, A Hadchouel, L Berteloot, I Melki… - The Journal of Allergy …, 2021 - Elsevier
Background Gain-of-function mutations in STING1 underlie a type I interferonopathy termed
SAVI (STING-associated vasculopathy with onset in infancy). This severe disease is variably …
被引用次数：132 相关文章

Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients.

ML Frémond, A Hadchouel, L Berteloot… - The journal of allergy …, 2020 - folia.unifr.ch
RESULTS Patients carried heterozygous substitutions in STING1 previously described in
SAVI, mainly the p. V155M. Most patients were symptomatic from infancy but late onset in …

Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

ML Frémond, A Hadchouel, L Berteloot… - The Journal of …, 2021 - jaci-inpractice.org
Background Gain-of-function mutations in STING1 underlie a type I interferonopathy termed
SAVI (STING-associated vasculopathy with onset in infancy). This severe disease is variably …
[DOC] ed.ac.uk

[DOC][DOC] Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients

ML Frémond, A Hadchouel, L Berteloot, I Melki… - research.ed.ac.uk
Background: Gain-of-function mutations in STING1 underlie a type I interferonopathy termed
SAVI (STING-associated vasculopathy with onset in infancy). This severe disease is variably …
[PDF] researchgate.net

[PDF][PDF] Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

ML Frémond, A Hadchouel, L Berteloot, I Melki… - researchgate.net
BACKGROUND: Gain-of-function mutations in STING1 underlie a type I interferonopathy
termed SAVI (STING-associated vasculopathy with onset in infancy). This severe disease is …

Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

ML Frémond, A Hadchouel, L Berteloot… - Journal of Allergy and …, 2021 - hal.science
Background: Gain-of-function mutations in STING1 underlie a type I interferonopathy termed
SAVI (STING-associated vasculopathy with onset in infancy). This severe disease is variably …

[引用][C] Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

ML Frémond, A Hadchouel, L Berteloot, I Melki… - The Journal of Allergy …, 2021 - cir.nii.ac.jp
Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

ML Frémond, A Hadchouel, L Berteloot… - Journal of Allergy and …, 2021 - inria.hal.science
Background: Gain-of-function mutations in STING1 underlie a type I interferonopathy termed
SAVI (STING-associated vasculopathy with onset in infancy). This severe disease is variably …

Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

ML Frémond, A Hadchouel, L Berteloot… - Journal of Allergy and …, 2021 - amu.hal.science
Background: Gain-of-function mutations in STING1 underlie a type I interferonopathy termed
SAVI (STING-associated vasculopathy with onset in infancy). This severe disease is variably …

Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

ML Frémond, A Hadchouel… - The journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Gain-of-function mutations in STING1 underlie a type I interferonopathy termed
SAVI (STING-associated vasculopathy with onset in infancy). This severe disease is variably …